Sanofi annual gross margin
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Sanofi's gross margin was 77.17% for fiscal 2025.
View full Sanofi company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 77.17% | +1.51 pp |
| 2024 | 2024-12-31 | 75.66% | −1.00 pp |
| 2023 | 2023-12-31 | 76.66% | +0.49 pp |
| 2022 | 2022-12-31 | 76.17% | +4.88 pp |
| 2021 | 2021-12-31 | 71.29% | +1.34 pp |
| 2020 | 2020-12-31 | 69.95% | −1.06 pp |
| 2019 | 2019-12-31 | 71.01% | +0.66 pp |
| 2018 | 2018-12-31 | 70.34% | +0.18 pp |
| 2017 | 2017-12-31 | 70.16% | −0.81 pp |
| 2016 | 2016-12-31 | 70.97% | +0.68 pp |
| 2015 | 2015-12-31 | 70.29% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|
Over the last five reported fiscal years, Sanofi's gross margin increased from 69.95% to 77.17%, a change of +7.22 percentage points.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sanofi filings at SEC.gov ↗